These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22849687)

  • 1. Effects of gemcitabine and gemcitabine in combination with carboplatin on five canine transitional cell carcinoma cell lines.
    de Brito Galvao JF; Kisseberth WC; Murahari S; Sutayatram S; Chew DJ; Inpanbutr N
    Am J Vet Res; 2012 Aug; 73(8):1262-72. PubMed ID: 22849687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
    McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
    Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine.
    Jian W; Yamashita H; Levitt JM; Lerner SP; Sonpavde G
    Mol Cancer Ther; 2009 Jul; 8(7):1772-8. PubMed ID: 19509273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
    Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK
    J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
    Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
    J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.
    Shang D; Liu Y; Matsui Y; Ito N; Nishiyama H; Kamoto T; Ogawa O
    Urology; 2008 Jun; 71(6):1220-5. PubMed ID: 18538698
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Byer B; Schlein LJ; Rose B; Séguin B
    Can J Vet Res; 2020 Apr; 84(2):115-123. PubMed ID: 32255906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines.
    Sakai K; Maeda S; Saeki K; Nakagawa T; Murakami M; Endo Y; Yonezawa T; Kadosawa T; Mori T; Nishimura R; Matsuki N
    Vet Comp Oncol; 2018 Dec; 16(4):642-649. PubMed ID: 30246405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine combined with sequential paclitaxel and carboplatin in patients with urothelial cancers and other advanced malignancies.
    DiPaola RS; Rubin E; Toppmeyer D; Eid J; Butzbach D; Dvorzhinski D; Capanna T; Cairdella M; Shih JW; Goodin S; Todd MB
    Med Sci Monit; 2003 Feb; 9(2):PI5-11. PubMed ID: 12601301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: effective treatment of patients with poor prognostic features.
    Shannon C; Crombie C; Brooks A; Lau H; Drummond M; Gurney H
    Ann Oncol; 2001 Jul; 12(7):947-52. PubMed ID: 11521800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells.
    Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC
    Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
    Packeiser EM; Hewicker-Trautwein M; Thiemeyer H; Mohr A; Junginger J; Schille JT; Murua Escobar H; Nolte I
    PLoS One; 2020; 15(3):e0230272. PubMed ID: 32168360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function].
    Helke C; May M; Hoschke B
    Aktuelle Urol; 2006 Sep; 37(5):363-8. PubMed ID: 17004181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.
    da Silva GN; de Castro Marcondes JP; de Camargo EA; da Silva Passos Júnior GA; Sakamoto-Hojo ET; Salvadori DM
    Exp Biol Med (Maywood); 2010 Jul; 235(7):814-24. PubMed ID: 20558835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
    Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
    J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Takeuchi H; Mmeje CO; Jinesh GG; Taoka R; Kamat AM
    Oncol Rep; 2015 Nov; 34(5):2738-44. PubMed ID: 26323344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined gemcitabine and carboplatin therapy for carcinomas in dogs.
    Dominguez PA; Dervisis NG; Cadile CD; Sarbu L; Kitchell BE
    J Vet Intern Med; 2009; 23(1):130-7. PubMed ID: 19175731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells.
    Fechner G; Perabo FG; Schmidt DH; Haase L; Ludwig E; Schueller H; Blatter J; Mller SC; Albers P
    Urology; 2003 Feb; 61(2):468-73. PubMed ID: 12597983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma.
    Hurwitz ME; Markowski P; Yao X; Deshpande H; Patel J; Mortazavi A; Donadio A; Stein MN; Kelly WK; Petrylak DP; Mehnert JM
    Clin Genitourin Cancer; 2018 Dec; 16(6):437-444.e6. PubMed ID: 30177237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of gemcitabine monotherapy in patients with transitional cell carcinoma after Cisplatin-containing therapy: a Japanese experience.
    Akaza H; Naito S; Usami M; Miki T; Miyanaga N; Taniai H;
    Jpn J Clin Oncol; 2007 Mar; 37(3):201-6. PubMed ID: 17452426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.